查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2132236

誘導性多功能幹細胞市場規模、佔有率和趨勢分析報告：按細胞類型、應用、最終用途、地區和細分市場預測（2026-2033 年）

Induced Pluripotent Stem Cells Market Size, Share & Trends Analysis Report By Derived Cell Type, By Application, By End Use, By Region, And Segment Forecasts, 2026 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

誘導性多功能幹細胞市場概覽

全球誘導性多功能幹細胞市場預計到 2025 年將達到 20 億美元，從 2026 年的 22 億美元成長到 2033 年的 48 億美元，2026 年至 2033 年的複合年成長率為 11.8%。

北美市場處於領先地位，預計到 2025 年將佔銷售額的 35.8%。慢性病盛行率上升、幹細胞療法研發活動活性化以及對個人化醫療的日益關注正在推動 iPS 細胞市場的成長。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章 市場：變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 產業分析工具

第4章：依派生儲存格類型進行業務分析

  • 誘導性多功能幹細胞市場：依衍生細胞類型分類的趨勢分析
  • 肝細胞
  • 纖維母細胞
  • 角質形成細胞
  • 羊水來源細胞
  • 其他

第5章 應用業務分析

  • 誘導性多功能幹細胞市場：按應用領域分類的趨勢分析
  • 藥物研發
  • 組織工程與再生醫學
  • 毒理學調查
  • 疾病建模

第6章：依最終用途進行業務分析

  • 誘導性多功能幹細胞市場：依最終用途分類的趨勢分析
  • 學術研究機構
  • 製藥和生物技術公司
  • 其他

第7章 區域業務分析

  • 誘導性多功能幹細胞市場佔有率：按地區分類，2025 年和 2033 年
  • 北美洲
    • 2021-2033年北美誘導性多功能幹細胞市場
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 2021-2033年歐洲誘導性多功能幹細胞市場
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 2021-2033年亞太地區誘導性多功能幹細胞市場
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 2021-2033年拉丁美洲誘導性多功能幹細胞市場
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 2021-2033年中東和非洲誘導性多功能幹細胞市場。
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭情勢

  • 公司分類
  • 企業市場占有率及定位分析，2025年
  • 策略規劃
  • 公司簡介列表
    • STEMCELL Technologies Inc.
    • 細胞工程技術公司
    • REPROCELL Inc.
    • Takara Bio, Inc.
    • Axol Bioscience Ltd.
    • Fate Therapeutics, Inc.
    • 富士膠片細胞動力學公司
    • Cynata Therapeutics Limited
    • Evotec SE
    • Astellas Pharma Inc.
Product Code: GVR-4-68040-116-1

Induced Pluripotent Stem Cells Market Summary

The global induced pluripotent stem cells market size was valued at USD 2.0 billion in 2025 and is projected to grow from USD 2.2 billion in 2026 to USD 4.8 billion by 2033, at a CAGR of 11.8% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 35.8% in 2025. The rising prevalence of chronic diseases, increasing research and development activities in stem cell therapies, and growing focus on personalized medicine drive the iPSC market growth.

Global Induced Pluripotent Stem Cells Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global induced pluripotent stem cells market on the basis of derived cell type, application, end use, and region:

  • Derived Cell Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Hepatocytes
  • Fibroblasts
  • Keratinocytes
  • Amniotic Cells
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Drug Development
  • Tissue Engineering & Regenerative Medicine
    • Neurology
    • Orthopedics
    • Oncology
    • Cardiovascular and Myocardial Infraction
    • Diabetes
    • Others
  • Toxicology Research
  • Disease Modeling
  • End use Outlook (Revenue, USD Million, 2021 - 2033)
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Derived Cell Type Segment
      • 1.1.1.2. Application Segment
      • 1.1.1.3. End-use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis:
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
    • 1.9.2. List of Secondary Sources
    • 1.9.3. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing Application of Regenerative Medicine
      • 3.2.1.2. Technology Advancement in iPSC Production
      • 3.2.1.3. Growing Prevalence of Chronic and Degenerative Diseases
      • 3.2.1.4. Expanding Applications in Disease Modeling and Drug Discovery
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Stringent Process Control and Regulatory Challenges
      • 3.2.2.2. Challenges in Large-Scale Commercialization and Reproducibility
      • 3.2.2.3. High Cost of Production
    • 3.2.3. Market Opportunities Analysis
    • 3.2.4. Market Challenges Analysis
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Economic landscape
      • 3.3.2.5. Legal landscape

Chapter 4. Derived Cell Type Business Analysis

  • 4.1. Segment Dashboard
  • 4.2. Induced Pluripotent Stem Cells Market: Derived Cell Type Movement Analysis
  • 4.3. Hepatocytes
    • 4.3.1. Hepatocytes Market, 2021 - 2033 (USD Million)
  • 4.4. Fibroblasts
    • 4.4.1. Fibroblasts Market, 2021 - 2033 (USD Million)
  • 4.5. Keratinocytes
    • 4.5.1. Keratinocytes Market, 2021 - 2033 (USD Million)
  • 4.6. Amniotic Cells
    • 4.6.1. Amniotic Cells Market, 2021 - 2033 (USD Million)
  • 4.7. Others
    • 4.7.1. Others Market, 2021 - 2033 (USD Million)

Chapter 5. Application Business Analysis

  • 5.1. Segment Dashboard
  • 5.2. Induced Pluripotent Stem Cells Market: Application Movement Analysis
  • 5.3. Drug Development
    • 5.3.1. Drug Development Market, 2021 - 2033 (USD Million)
  • 5.4. Tissue Engineering & Regenerative Medicine
    • 5.4.1. Tissue Engineering & Regenerative Medicine Market, 2021 - 2033 (USD Million)
    • 5.4.2. Neurology
      • 5.4.2.1. Neurology Market, 2021 - 2033 (USD Million)
    • 5.4.3. Orthopedics
      • 5.4.3.1. Orthopedics Market, 2021 - 2033 (USD Million)
    • 5.4.4. Oncology
      • 5.4.4.1. Oncology Market, 2021 - 2033 (USD Million)
    • 5.4.5. Cardiovascular and Myocardial Infarction
      • 5.4.5.1. Cardiovascular and Myocardial Infarction Market, 2021 - 2033 (USD Million)
    • 5.4.6. Diabetes
      • 5.4.6.1. Diabetes Market, 2021 - 2033 (USD Million)
    • 5.4.7. Others
      • 5.4.7.1. Others Market, 2021 - 2033 (USD Million)
  • 5.5. Toxicology Research
    • 5.5.1. Toxicology Research Market, 2021 - 2033 (USD Million)
  • 5.6. Disease Modeling
    • 5.6.1. Disease Modeling Market, 2021 - 2033 (USD Million)

Chapter 6. End Use Business Analysis

  • 6.1. Segment Dashboard
  • 6.2. Induced Pluripotent Stem Cells Market: End-use Movement Analysis
  • 6.3. Academic & Research Institutes
    • 6.3.1. Academic & Research Institutes Market, 2021 - 2033 (USD Million)
  • 6.4. Pharmaceutical & Biotechnology Companies
    • 6.4.1. Pharmaceutical & Biotechnology Companies Market, 2021 - 2033 (USD Million)
  • 6.5. Others
    • 6.5.1. Others Market, 2021 - 2033 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Induced Pluripotent Stem Cells Market Share By Region, 2025 & 2033
  • 7.2. North America
    • 7.2.1. North America Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Competitive Scenario
      • 7.2.2.3. Regulatory Framework
      • 7.2.2.4. U.S. Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Competitive Scenario
      • 7.2.3.3. Regulatory Framework
      • 7.2.3.4. Canada Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Key Country Dynamics
      • 7.2.4.2. Competitive Scenario
      • 7.2.4.3. Regulatory Framework
      • 7.2.4.4. Mexico Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. UK Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Germany Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. France Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Competitive Scenario
      • 7.3.5.3. Regulatory Framework
      • 7.3.5.4. Italy Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Competitive Scenario
      • 7.3.6.3. Regulatory Framework
      • 7.3.6.4. Spain Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Competitive Scenario
      • 7.3.7.3. Regulatory Framework
      • 7.3.7.4. Denmark Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Competitive Scenario
      • 7.3.8.3. Regulatory Framework
      • 7.3.8.4. Sweden Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Competitive Scenario
      • 7.3.9.3. Regulatory Framework
      • 7.3.9.4. Norway Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Japan Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. China Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. India Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Australia Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
    • 7.4.6. Thailand
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Thailand Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
    • 7.4.7. South Korea
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. South Korea Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Brazil Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Argentina Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • 7.6. MEA
    • 7.6.1. MEA Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. South Africa Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Saudi Arabia Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. UAE Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Kuwait Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Company Market Share/ Position Analysis, 2025
  • 8.3. Strategy Mapping
  • 8.4. Company Profiles/Listing
    • 8.4.1. STEMCELL Technologies Inc.
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Cellular Engineering Technologies Inc.
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. REPROCELL Inc.
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Takara Bio, Inc.
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Axol Bioscience Ltd.
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Fate Therapeutics, Inc.
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. FUJIFILM Cellular Dynamics, Inc.
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Cynata Therapeutics Limited
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Evotec SE
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Astellas Pharma Inc.
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 4 Global induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 5 Global induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 6 Global induced pluripotent stem cells market, by region, 2021 - 2033 (USD Million)
  • Table 7 North America induced pluripotent stem cells market, by country, 2021 - 2033 (USD Million)
  • Table 8 North America induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 9 North America induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 10 North America induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 11 U.S. induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 12 U.S. induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 13 U.S. induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 14 Canada induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 15 Canada induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 16 Canada induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 17 Mexico induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 18 Mexico induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 19 Mexico induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 20 Europe induced pluripotent stem cells market, by country, 2021 - 2033 (USD Million)
  • Table 21 Europe induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 22 Europe induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 23 Europe induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 24 UK induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 25 UK induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 26 UK induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 27 Germany induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 28 Germany induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 29 Germany induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 30 France induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 31 France induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 32 France induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 33 Italy induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 34 Italy induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 35 Italy induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 36 Spain induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 37 Spain induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 38 Spain induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 39 Denmark induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 40 Denmark induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 41 Denmark induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 42 Sweden induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 43 Sweden induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 44 Sweden induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 45 Norway induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 46 Norway induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 47 Norway induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific induced pluripotent stem cells market, by country, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 51 Asia Pacific induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 52 Japan induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 53 Japan induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 54 Japan induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 55 China induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 56 China induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 57 China induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 58 India induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 59 India induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 60 India induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 61 Australia induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 62 Australia induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 63 Australia induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 64 Thailand induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 65 Thailand induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 66 Thailand induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 67 South Korea induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 68 South Korea induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 69 South Korea induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 70 Latin America induced pluripotent stem cells market, by country, 2021 - 2033 (USD Million)
  • Table 71 Latin America induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 72 Latin America induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 73 Latin America induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 74 Brazil induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 75 Brazil induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 76 Brazil induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 77 Argentina induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 78 Argentina induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 79 Argentina induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 80 Middle East & Africa induced pluripotent stem cells market, by country, 2021 - 2033 (USD Million)
  • Table 81 Middle East & Africa induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 82 Middle East & Africa induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 83 Middle East & Africa induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 84 South Africa induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 85 South Africa induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 86 South Africa induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 89 Saudi Arabia induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 90 UAE induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 91 UAE induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 92 UAE induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 93 Kuwait induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 94 Kuwait induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 95 Kuwait induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Induced pluripotent stem cells market segmentation
  • Fig. 8 Market snapshot, 2025
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 PESTLE analysis
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Market penetration & growth prospect mapping, 2025
  • Fig. 15 Global Induced Pluripotent Stem Cells Market: Derived cell type movement analysis
  • Fig. 16 Global Induced Pluripotent Stem Cells Market, for Hepatocytes, 2021 - 2033 (USD Million)
  • Fig. 17 Global Induced Pluripotent Stem Cells Market, for Fibroblasts, 2021 - 2033 (USD Million)
  • Fig. 18 Global Induced Pluripotent Stem Cells Market, for Keratinocytes, 2021 - 2033 (USD Million)
  • Fig. 19 Global Induced Pluripotent Stem Cells Market, for Amniotic Cells, 2021 - 2033 (USD Million)
  • Fig. 20 Global Induced Pluripotent Stem Cells Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 21 Global Induced Pluripotent Stem Cells Market: Application movement analysis
  • Fig. 22 Global Induced Pluripotent Stem Cells Market, for Drug Development and Discovery, 2021 - 2033 (USD Million)
  • Fig. 23 Global Induced Pluripotent Stem Cells Market, for Tissue Engineering & Regenerative Medicine, 2021 - 2033 (USD Million)
  • Fig. 24 Global Induced Pluripotent Stem Cells Market, for Neurology, 2021 - 2033 (USD Million)
  • Fig. 25 Global Induced Pluripotent Stem Cells Market, for Orthopedics, 2021 - 2033 (USD Million)
  • Fig. 26 Global Induced Pluripotent Stem Cells Market, for Oncology, 2021 - 2033 (USD Million)
  • Fig. 27 Global Induced Pluripotent Stem Cells Market, for Cardiovascular and Myocardial Infraction, 2021 - 2033 (USD Million)
  • Fig. 28 Global Induced Pluripotent Stem Cells Market, for Diabetes, 2021 - 2033 (USD Million)
  • Fig. 29 Global Induced Pluripotent Stem Cells Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 30 Global Induced Pluripotent Stem Cells Market, for Toxicology Studies, 2021 - 2033 (USD Million)
  • Fig. 31 Global Induced Pluripotent Stem Cells Market, for Disease Modeling, 2021 - 2033 (USD Million)
  • Fig. 32 Global Induced Pluripotent Stem Cells Market: End-use movement analysis
  • Fig. 33 Global Induced Pluripotent Stem Cells Market, for Research and Academic Institutes, 2021 - 2033 (USD Million)
  • Fig. 34 Global Induced Pluripotent Stem Cells Market, for Biotechnology & Pharmaceutical Companies, 2021 - 2033 (USD Million)
  • Fig. 35 Global Induced Pluripotent Stem Cells Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 36 Regional marketplace: Key takeaways
  • Fig. 37 Regional outlook, 2025 & 2033
  • Fig. 38 Global Induced Pluripotent Stem Cells Market: Region movement analysis
  • Fig. 39 North America Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 40 U.S. Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 41 Canada Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 42 Mexico Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 43 Europe Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 44 Germany Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 45 UK Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 46 France Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 47 Italy Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 48 Spain Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 49 Denmark Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 50 Sweden Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 51 Norway Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 52 Asia Pacific Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 53 Japan Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 54 China Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 55 India Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 56 Australia Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 57 South Korea Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 58 Thailand Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 59 Latin America Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 60 Brazil Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 61 Argentina Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 62 Middle East and Africa Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 63 South Africa Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 64 Saudi Arabia Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 65 UAE Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 66 Kuwait Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)